Annette Marcantonio
Corporate Officer/Principal bij JASPER THERAPEUTICS, INC.
Profiel
Annette Marcantonio is currently the Vice President of Clinical Operations at Jasper Therapeutics, Inc. Prior to this, she held the same position at Aimmune Therapeutics, Inc. from 2016 to 2020.
She received her undergraduate degree from Loyola Marymount University.
Actieve functies van Annette Marcantonio
| Bedrijven | Functie | Begin |
|---|---|---|
| JASPER THERAPEUTICS, INC. | Corporate Officer/Principal | 02-08-2023 |
Eerdere bekende functies van Annette Marcantonio
| Bedrijven | Functie | Einde |
|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | Corporate Officer/Principal | 01-10-2020 |
Opleiding van Annette Marcantonio
| Loyola Marymount University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| JASPER THERAPEUTICS, INC. | Finance |
| Bedrijven in privébezit | 1 |
|---|---|
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
